A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

Tweed, C D; Wills, G H; Crook, A M; Amukoye, E; Balanag, V; Ban, A Y L; Bateson, A L C; Betteridge, M C; Brumskine, W; Caoili, J; Chaisson, R E; Cevik, M; Conradie, F; Dawson, R; Del Parigi, A; Diacon, A; Everitt, D E; Fabiane, S M; Hunt, R; Ismail, A I; Lalloo, U; Lombard, L; Louw, C; Malahleha, M; McHugh, T D; Mendel, C M; Mhimbira, F; Moodliar, R N; Nduba, V; Nunn, A J; Sabi, I; Sebe, M A; Selepe, R A P; Staples, S; Swindells, S; van Niekerk, C H; Variava, E; Spigelman, M; Gillespie, S H

Tweed, C D; Wills, G H; Crook, A M; Amukoye, E; Balanag, V; Ban, A Y L; Bateson, A L C; Betteridge, M C; Brumskine, W; Caoili, J; Chaisson, R E; Cevik, M; Conradie, F; Dawson, R; Del Parigi, A; Diacon, A; Everitt, D E; Fabiane, S M; Hunt, R; Ismail, A I; Lalloo, U; Lombard, L; Louw, C; Malahleha, M; McHugh, T D; Mendel, C M; Mhimbira, F; Moodliar, R N; Nduba, V; Nunn, A J; Sabi, I; Sebe, M A; Selepe, R A P; Staples, S; Swindells, S; van Niekerk, C H; Variava, E; Spigelman, M; Gillespie, S H.

Affiliation

Tweed CD; Medical Research Council Clinical Trials Unit, University College London (UCL), London, UK.
Wills GH; Medical Research Council Clinical Trials Unit, University College London (UCL), London, UK.
Crook AM; Medical Research Council Clinical Trials Unit, University College London (UCL), London, UK.
Amukoye E; Centre for Respiratory Disease Research, Kenya Medical Research Institute (KEMRI), Kenyatta National Hospital, Nairobi, Kenya.
Balanag V; Lung Center of the Philippines, National Centre for Pulmonary Research, Quezon City, The Philippines.
Ban AYL; Pusat Perubatan Universiti Kebangsaan, Kuala Lumpur, Malaysia.
Bateson ALC; Centre for Clinical Microbiology, UCL, London, UK.
Betteridge MC; Global Alliance for TB Drug Development, New York, NY, USA.
Brumskine W; Aurum Institute, Rustenburg, South Africa.
Caoili J; Tropical Disease Foundation, Makati Medical Centre, Makati City, Phillippines.
Chaisson RE; School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Cevik M; Medical School, University of St Andrews, St Andrews, UK.
Conradie F; University of the Witwatersrand, Clinical HIV Research Unit, Johannesburg.
Dawson R; University of Cape Town Lung Institute, Cape Town.
Del Parigi A; Global Alliance for TB Drug Development, New York, NY, USA.
Diacon A; TASK Applied Science, Bellville, South Africa & Division of Physiology, Department of Medical Biochemistry, University of Stellenbosch, Tygerberg, South Africa.
Everitt DE; Global Alliance for TB Drug Development, New York, NY, USA.
Fabiane SM; Medical Research Council Clinical Trials Unit, University College London (UCL), London, UK.
Hunt R; Centre for Clinical Microbiology, UCL, London, UK.
Ismail AI; Universiti Teknologi MARA, Selangor, Malaysia.
Lalloo U; Enhancing Care Foundation, Durban International Clinical Research Site, Wentworth Hospital, Durban.
Lombard L; Global Alliance for TB Drug Development, New York, NY, USA.
Louw C; Madibeng Centre for Research, Brits, & Department of Family Medicine, University of Pretoria, Pretoria.
Malahleha M; Setshaba Research Centre, Soshanguve, South Africa.
McHugh TD; Centre for Clinical Microbiology, UCL, London, UK.
Mendel CM; Global Alliance for TB Drug Development, New York, NY, USA.
Mhimbira F; Ifakara Health Institute (IHI), Dar es Salaam, Tanzania.
Moodliar RN; THINK (Tuberculosis and HIV Investigative Network), Durban, South Africa.
Nduba V; KEMRI, Nairobi, Kenya.
Nunn AJ; Medical Research Council Clinical Trials Unit, University College London (UCL), London, UK.
Sabi I; Mbeya Medical Research Center, National Institute for Medical Research, Mbeya, Tanzania.
Sebe MA; The Aurum Institute, Tembisa Clinical Research Centre, Tembisa.
Selepe RAP; The Aurum Institute, Klerksdorp, South Africa.
Staples S; THINK (Tuberculosis and HIV Investigative Network), Durban, South Africa.
Swindells S; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
van Niekerk CH; Global Alliance for TB Drug Development, Pretoria.
Variava E; Klerksdorp Tshepong Hospital, Klerksdorp, South Africa.
Spigelman M; Global Alliance for TB Drug Development, New York, NY, USA.
Gillespie SH; Medical School, University of St Andrews, St Andrews, UK.

Int J Tuberc Lung Dis ; 25(4): 305-314, 2021 04 01.

Article de En | MEDLINE | ID: mdl-33762075

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrazinamide / Tuberculose / Antituberculeux Type d'étude: Clinical_trials / Guideline Limites: Humans Langue: En Journal: Int J Tuberc Lung Dis Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: France

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google